Scientists Uncover Method to Reactivate Silenced Friedreich's Ataxia Gene

Researchers at St. Jude Children's Research Hospital have discovered a novel mechanism to reactivate the frataxin gene, which is abnormally silenced in Friedreich's ataxia, a neurodegenerative disease. Published in Nature Cell Biology, the study reveals how a synthetic gene regulator can penetrate tightly packaged DNA to activate the dormant gene, challenging previous assumptions about gene silencing and offering new avenues for therapeutic development.